Repare Therapeutics Eulerpool naujienos

Repare Therapeutics akcijų naujienos

Repare Therapeutics stebi daugybė žurnalistų ir investuotojų visame pasaulyje. Naujausias Repare Therapeutics naujienas mes pateikiame čia.

• lapkričio 12 d. ·

  Yahoo
  Repare Therapeutics Announces Agreement with the US National Cancer Institute to Advance the Development of Camonsertib
• lapkričio 7 d. ·

  Yahoo
  Repare Therapeutics Provides Business and Clinical Update and Reports Third Quarter 2024 Financial Results
• spalio 24 d. ·

  TipRanks
  Repare Therapeutics Receives Buy Rating Due to Improved Treatment Tolerability and Promising Clinical Outcomes
• spalio 24 d. ·

  Yahoo
  Repare Therapeutics’ individualised anaemia management trial shows promise
• spalio 24 d. ·

  TipRanks
  TD Cowen Sticks to Its Buy Rating for Repare Therapeutics (RPTX)
• spalio 23 d. ·

  Yahoo
  Repare Therapeutics Announces Updated Positive Safety and Tolerability Results from the Phase 1 MYTHIC Clinical Trial
• spalio 23 d. ·

  Thefly.com
  Repare Therapeutics presents data from Phase 1 MYTHIC clinical trial
• spalio 15 d. ·

  Yahoo
  RPTX Stock Up as Dosing Begins in Solid Tumor Study for Combo Drug
• spalio 14 d. ·

  Yahoo
  Repare Therapeutics Doses First Patient in Phase 1 Clinical Trial of RP-3467, a Polθ ATPase Inhibitor
• spalio 14 d. ·

  Thefly.com
  Repare Therapeutics doses first patient in POLAR trial